Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Microbiol., 31 December 2025

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 16 - 2025 | https://doi.org/10.3389/fmicb.2025.1741710

Correction: Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

This article is a correction to:

  1. Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

    1. Read original article
Natalia S&#x;abisz Natalia Słabisz1*Patrycja Le nikPatrycja Leśnik2Jaros&#x;aw JancJarosław Janc3Mi&#x;osz FidutMiłosz Fidut4Marzenna BartoszewiczMarzenna Bartoszewicz5Ruth Dudek-WicherRuth Dudek-Wicher5Urszula NawrotUrszula Nawrot5
  • 1Department of Laboratory Diagnostic, 4th Military Clinical Hospital, Wroclaw, Poland
  • 2Department of Microbiology, Wroclaw Medical University, Wroclaw, Poland
  • 3Department of Anaesthesiology and Intensive Therapy, Hospital of Ministry of the Interior and Administration, Wroclaw, Poland
  • 4Department of Cardiology, 4th Military Clinical Hospital, Wroclaw, Poland
  • 5Department of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, Wroclaw, Poland

A Correction on
Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections

by Słabisz, N., Leśnik, P., Janc, J., Fidut, M., Bartoszewicz, M., Dudek-Wicher, R., and Nawrot, U. (2024). Front. Microbiol. 15:1331628. doi: 10.3389/fmicb.2024.1331628

In the published version, the Funding statement reads:

“The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.”

This information is incomplete. The correct Funding statement should be:

“The author(s) declared that financial support was received for this work and/or its publication. Publication of this article was supported by Wroclaw Medical University statutory grant number SUBZ.D230.24.001.”

The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Klebsiella pneumoniae, metallo-beta-lactamase, NDM, susceptibility, aztreonam, eravacycline, fosfomycin, tigecycline

Citation: Słabisz N, Leśnik P, Janc J, Fidut M, Bartoszewicz M, Dudek-Wicher R and Nawrot U (2025) Correction: Evaluation of the in vitro susceptibility of clinical isolates of NDM-producing Klebsiella pneumoniae to new antibiotics included in a treatment regimen for infections. Front. Microbiol. 16:1741710. doi: 10.3389/fmicb.2025.1741710

Received: 07 November 2025; Accepted: 28 November 2025;
Published: 31 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Słabisz, Leśnik, Janc, Fidut, Bartoszewicz, Dudek-Wicher and Nawrot. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Natalia Słabisz, bmF0YWxpYXNsYWJpc3pAZ21haWwuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.